SCHEMBL7480971

SCHEMBL7480971

COc1cc(C(=O)N(C)c2ccc(C)cc2OCCCCCN2C(=O)c3ccccc3C2=O)ccc1[N+](=O)[O-]

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.51
LMNA P02545 2/20 0.51
AGTR1 P30556 1/20 0.51
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
GAA P10253 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
RAB9A P51151 1/20 0.45
HTT P42858 1/20 0.42
KDM4E B2RXH2 2/20 0.42
HPGD P15428 2/20 0.42
MAPK1 P28482 2/20 0.41
KEAP1 Q14145 1/20 0.41
NFE2L2 Q16236 1/20 0.41
POLB P06746 2/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
TSHR P16473 1/20 0.40
MAOB P27338 1/20 0.39
PKM P14618 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7373903 0.97 ALDH1A1 (0.52) ALDH1A1LMNAAGTR1MEN1KMT2A
SCHEMBL7372163 0.88 RAB9A (0.49) ALDH1A1LMNAAGTR1MEN1KMT2A
SCHEMBL7373593 0.86 ALDH1A1 (0.43) ALDH1A1LMNAMEN1KMT2AGAA
SCHEMBL7417588 0.85 HTT (0.47) ALDH1A1LMNAGAANPSR1HTT
SCHEMBL7426873 0.84 POLB (0.44) ALDH1A1LMNAAGTR1MEN1KMT2A
SCHEMBL7345680 0.84 ALDH1A1 (0.43) ALDH1A1LMNAMEN1KMT2AGAA
SCHEMBL7371731 0.84 KDM4E (0.51) ALDH1A1LMNAMEN1KMT2AGAA
SCHEMBL7474710 0.83 ALDH1A1 (0.54) ALDH1A1LMNAAGTR1MEN1KMT2A
SCHEMBL7376935 0.82 ALDH1A1 (0.43) ALDH1A1LMNAMEN1KMT2AGAA
SCHEMBL7338369 0.81 TNF (0.42) ALDH1A1LMNAMEN1KMT2AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6316482-B1 FOR THERAPY AND PROPHYLAXIS OF HYPERTENSION, HEART FAILURE, RENAL INSUFFICIENCY, EDEMA, ASCITES, VASOPRESSIN PARASECRETION SYNDROME, HEPATOCIRRHOSIS, HYPONATREMIA, HYPOKALEMIA, DIABETIC, CIRCULATION DISORDER, CEREBROVASCULAR DISEASE FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-11-13 US disclosed
US-6207693-B1 Benzamide derivatives having a vasopressin antagonistic activity FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-03-27 US disclosed
EP-0946519-A1 BENZAMIDE DERIVATIVES HAVING A VASOPRESSIN ANTAGONISTIC ACTIVITY FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-10-06 EP disclosed
WO-1998024771-A1 BENZAMIDE DERIVATIVES HAVING A VASOPRESSIN ANTAGONISTIC ACTIVITY FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-06-11 WO disclosed